United States v. Marcus

849 F. Supp. 417, 1994 U.S. Dist. LEXIS 5384, 1994 WL 157606
CourtDistrict Court, D. Maryland
DecidedApril 21, 1994
DocketCrim. PJM 93-0286
StatusPublished
Cited by1 cases

This text of 849 F. Supp. 417 (United States v. Marcus) is published on Counsel Stack Legal Research, covering District Court, D. Maryland primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Marcus, 849 F. Supp. 417, 1994 U.S. Dist. LEXIS 5384, 1994 WL 157606 (D. Md. 1994).

Opinion

OPINION

MESSITTE, District Judge.

I.

In this ease, joining the nearly unanimous opinion of courts that have spoken to the issue, the Court holds that a prosecutor’s use of a wired informant for the purpose of recording conversations with the represented target of a criminal investigation, even to the point of suggesting topics to be discussed, does not violate professional disciplinary rules. Accordingly, the Court denies the motions of the several Defendants to suppress certain wire recordings.

II.

In the late 1980s, Congress launched an investigation into reported widespread abuses in the generic drug industry in this country. By the summer of 1989, the U.S. Food and Drug Administration (FDA) had commenced extraordinary inspections of some 20 generic drug firms, including Halsey Drug Company, Inc. of Brooklyn, New York (Halsey). Finding irregularities in the documentation of some of Halsey’s research and development batches and suspecting fraud in Halsey’s Abbreviated New Drug Applications, FDA transmitted Halsey’s name to the Justice Department’s Office of Consumer Litigation for criminal investigation. The Justice Department, through the’ U.S. Attorney’s Office in the District of Maryland, subsequently commenced a grand jury investigation of Halsey and on July 25, 1991, issued a subpoena to Halsey, requesting certain documents.

Halsey responded to the subpoena, represented by the Baltimore law firm of Piper & Marbury. The records they submitted, while confirming certain irregularities in documentation, did not explain those irregularities to the Government’s satisfaction.

In' February, 1993, FDA came upon what it believed was an explanation. A former Halsey employee, meeting with FDA’s New York District representatives, indicated that for certain products Halsey maintained alternate formulae on handwritten “phony cards.” These cards allegedly set out unapproved or altered formulae for drugs as opposed to the FDA-approved formulae. The former employee told FDA that Halsey’s management had directed its employees to follow these alternative formulae, but to fill out false production batch records for the products so it would appear that the FDA-approved formu-lae had in fact been followed. Allegedly Halsey’s granulation supervisor kept these “phony cards” hidden from FDA’s inspectors. The former employee provided photocopies of what he identified as “phony cards” for generic drug products Quinidine Gluconate 324 mg tablets and Metronidazole 250 mg tablets, and orally described deviations from approved master formulae in connection with other products including Acetaminophen and Codeine Phosphate tablets.

On March 2, 1993, the former employee, joined by a second former employee who corroborated the testimony, appeared before the grand jury in Baltimore and repeated the statements earlier made to FDA’s investigators, further testifying that Halsey was still following the “phony card” formulae as of the time they had left the company’s employ.

In the meantime, Christopher B. Mead, an Assistant U.S. Attorney in the Office of the U.S. Attorney for the District of Maryland, in consultation with an FDA bioequivalent expert, concluded that Halsey’s alternate formula for Quinidine Gluconate, used to treat irregular’ heartbeats, posed a potential health threat. The Government thus had grounds to believe as of that time (1) that Halsey might yet be adding unapproved ingredients to the heart medication; (2) that it was falsifying batch records even while under grand jurv investigation; and (3) that it was obstructing the grand jury’s investigation by not turning over documentation clearly responsive to the subpoena that had been served in 1991. 1

*419 The investigation went forward quickly. Government investigators had also learned during the grand jury testimony of the former Halsey employees that Halsey’s granulation supervisor, Marlon Forde, was an illegal alien. Working through the Federal Bureau of Investigation and the Immigration and Naturalization Service, AUSA Mead arranged for agents to confront Forde and promise him leniency if he would agree to wear a body recorder and engage 'Halsey’s management in conversation about the “phony cards.” On March 3, 1993, after Government agents confronted Forde and put him in telephone contact with Mead, Forde agreed to wear the body wire.

Mead instructed Forde to report to work at Halsey the next day and advise management personnel that he had been confronted by FDA agents who asked about the “phony cards,” particularly Quinidine Gluconate. He was further instructed to- say that he had refused to speak with the agents but to ask Halsey’s managers for advice as to what to do. On March 4, wearing a body recorder, Forde proceeded as planned, engaging all the Defendants in potentially incriminating conversations about the “phony cards.”

In addition, Defendant Marcus, Halsey’s President, told Forde he would- arrange for him to speak to the company lawyer the next day. Listening to the tape that evening, the special prosecution staff agents instructed Forde to wear the wire to work the next day and inquire of Marcus what it was he (Forde) should say to the company lawyer about Qui-nidine Gluconate. One of the agents specifically instructed Forde to turn off the body recorder if he had any direct dealings with the company lawyer, as opposed to Marcus, in order to avoid infringing upon any privileged conversations. AUSA Mead knew of this plan and approved it. On March 5, Forde again engaged Defendant Marcus in conversation, capturing further potentially incriminating conversations on tape, particularly with reference to Quinidine Gluconate.

On March 8, Mead met with Halsey’s attorneys and served them with another grand jury subpoena, this time requesting among other things all “phony cards” in Halsey’s possession. Because he wished to preserve Forde’s operational capability, Mead did not advise counsel of Forde’s cooperation. Halsey’s attorneys, after conducting an investigation on their own, promptly produced some of the “phony cards” and agreed to recall any products related to those cards.

In July, 1993, on the basis of the Government’s accumulated evidence, the grand jury indicted Defendant Marcus, Halsey’s President and Chief Executive Officer; Defendant Herman, the company’s Assistant Vice-President of Manufacturing; and Defendant Sha-infeld, the company’s Senior Vice-President of Technical and Regulatory Affairs and New Product Development.

III.

Defendants have moved to suppress the tapes of their respective recorded conversations 2 , alleging that, given the Government’s *420 knowledge that Halsey was represented by legal counsel, the taping of management level employees violated DR 7-104(A)(l) of the American Bar Association’s Model Code of Professional Responsibility. The Government vigorously denying that its preindictment undercover contacts with Defendants, even if they were represented, violated any ethical rules of this Court, urges that Defendants’ Motions be denied.

IV.

The disciplinary rule upon which Defendants place their reliance upon is straightforward enough. DR 7-104(A)(1) (1983) provides that:

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Joseph Binder Schweizer Emplem Co.
167 F. Supp. 2d 862 (E.D. North Carolina, 2001)

Cite This Page — Counsel Stack

Bluebook (online)
849 F. Supp. 417, 1994 U.S. Dist. LEXIS 5384, 1994 WL 157606, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-marcus-mdd-1994.